全文获取类型
收费全文 | 31442篇 |
免费 | 2681篇 |
国内免费 | 155篇 |
专业分类
耳鼻咽喉 | 274篇 |
儿科学 | 1095篇 |
妇产科学 | 818篇 |
基础医学 | 4258篇 |
口腔科学 | 648篇 |
临床医学 | 3378篇 |
内科学 | 6348篇 |
皮肤病学 | 585篇 |
神经病学 | 3483篇 |
特种医学 | 744篇 |
外科学 | 3211篇 |
综合类 | 467篇 |
一般理论 | 44篇 |
预防医学 | 3995篇 |
眼科学 | 557篇 |
药学 | 1949篇 |
1篇 | |
中国医学 | 41篇 |
肿瘤学 | 2382篇 |
出版年
2023年 | 417篇 |
2022年 | 732篇 |
2021年 | 1325篇 |
2020年 | 854篇 |
2019年 | 1134篇 |
2018年 | 1218篇 |
2017年 | 936篇 |
2016年 | 975篇 |
2015年 | 1043篇 |
2014年 | 1366篇 |
2013年 | 1744篇 |
2012年 | 2482篇 |
2011年 | 2532篇 |
2010年 | 1311篇 |
2009年 | 1132篇 |
2008年 | 1725篇 |
2007年 | 1661篇 |
2006年 | 1574篇 |
2005年 | 1398篇 |
2004年 | 1233篇 |
2003年 | 1022篇 |
2002年 | 950篇 |
2001年 | 376篇 |
2000年 | 348篇 |
1999年 | 335篇 |
1998年 | 190篇 |
1997年 | 177篇 |
1996年 | 157篇 |
1995年 | 150篇 |
1994年 | 123篇 |
1993年 | 125篇 |
1992年 | 248篇 |
1991年 | 219篇 |
1990年 | 235篇 |
1989年 | 228篇 |
1988年 | 229篇 |
1987年 | 175篇 |
1986年 | 175篇 |
1985年 | 178篇 |
1984年 | 146篇 |
1983年 | 125篇 |
1982年 | 102篇 |
1981年 | 92篇 |
1979年 | 126篇 |
1978年 | 109篇 |
1977年 | 88篇 |
1974年 | 86篇 |
1973年 | 107篇 |
1972年 | 97篇 |
1971年 | 82篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Victoria L. Parker Matthew C. Winter John A. Tidy Barry W. Hancock Julia E. Palmer Naveed Sarwar Baljeet Kaur Katie McDonald Xianne Aguiar Kamaljit Singh Nick Unsworth Imran Jabbar Allan A. Pacey Robert F. Harrison Michael J. Seckl 《International journal of cancer. Journal international du cancer》2023,152(5):986-997
Gestational trophoblastic neoplasia (GTN) patients are treated according to the eight-variable International Federation of Gynaecology and Obstetrics (FIGO) scoring system, that aims to predict first-line single-agent chemotherapy resistance. FIGO is imperfect with one-third of low-risk patients developing disease resistance to first-line single-agent chemotherapy. We aimed to generate simplified models that improve upon FIGO. Logistic regression (LR) and multilayer perceptron (MLP) modelling (n = 4191) generated six models (M1-6). M1, all eight FIGO variables (scored data); M2, all eight FIGO variables (scored and raw data); M3, nonimaging variables (scored data); M4, nonimaging variables (scored and raw data); M5, imaging variables (scored data); and M6, pretreatment hCG (raw data) + imaging variables (scored data). Performance was compared to FIGO using true and false positive rates, positive and negative predictive values, diagnostic odds ratio, receiver operating characteristic (ROC) curves, Bland-Altman calibration plots, decision curve analysis and contingency tables. M1-6 were calibrated and outperformed FIGO on true positive rate and positive predictive value. Using LR and MLP, M1, M2 and M4 generated small improvements to the ROC curve and decision curve analysis. M3, M5 and M6 matched FIGO or performed less well. Compared to FIGO, most (excluding LR M4 and MLP M5) had significant discordance in patient classification (McNemar's test P < .05); 55-112 undertreated, 46-206 overtreated. Statistical modelling yielded only small gains over FIGO performance, arising through recategorisation of treatment-resistant patients, with a significant proportion of under/overtreatment as the available data have been used a priori to allocate primary chemotherapy. Streamlining FIGO should now be the focus. 相似文献
3.
4.
5.
6.
In 1963, Goffman argued that forming a group based on shared stigma may provide benefits. However, there is no empirical research on whether perception that a separate, unique, coherent group exists (i.e., group entitativity) influences coping, such as educating others or secrecy, for the stigmatized individual or his or her spouse. Further, little is known about how spouses influence each other in terms of promoting the education of others about a stigmatizing condition, especially when it comes to the role of believing that stigma-based groups, to which they may both belong, exist. This study provides a step toward bridging this gap in the research by applying the label management model in efforts to understand coping for couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). This study included 50 married couples in which one spouse is diagnosed with genetic mutations leading to alpha-1 antitrypsin deficiency (AATD). We found that group entitativity related to those with AATD counterbalanced the influence of genetic stigma on spouses’ intentions to keep the diagnosis secret or to educate others about it. Intrapersonal and interpersonal influences appeared among spouses. Attention is needed on the power of creating groups for stigmatized persons and their relatives. Indeed, people live within a dynamic world of group entities, and multiple social identities including spousal and familial. While attention has been paid to the diffusion of stigmas to loved ones, less has been paid to the uplift of group entities for them. 相似文献
7.
8.
9.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
10.